The FDA has has approved Stelara (ustekinumab) for self-administration.
The biologic agent was previously intended for subcutaneous administration under the supervision of a doctor. Stelara can now be administered by patients at home. The drug is approved for the treatment of adult patients with moderate to severe plaque psoriasis.
[Source: Dermawire]